Area of research
Immunology and Allergy · Physiology
Research interest
Research interests include Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Respiratory and Cough-Related Research, and Dermatology and Skin Diseases.
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
WAO - ARIA consensus on chronic cough: Executive summary
Food allergy severity across the world: A World Allergy Organization international survey
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>
Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Comparison of rhinitis treatments using <scp>MASK</scp>‐air® data and considering the minimal important difference
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <scp>MASK</scp>‐air® longitudinal study
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
Presentation of airway and general symptoms in COVID‐19 caused by dominant <scp>SARS‐CoV</scp>‐2 variants: A follow‐up on <scp>ARIA</scp> consensus
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19
WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air
WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
Olfactory and taste dysfunctions in COVID-19
International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants
A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020
COVID-19, asthma, and biological therapies: What we need to know
Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD)
Spices to Control COVID-19 Symptoms: Yes, but Not Only…